financetom
Business
financetom
/
Business
/
Renasant Q2 Earnings Decline, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Renasant Q2 Earnings Decline, Revenue Increases
Jul 23, 2024 2:29 PM

05:11 PM EDT, 07/23/2024 (MT Newswires) -- Renasant ( RNST ) reported Q2 adjusted earnings Tuesday of $0.69 per diluted share, down from $0.83 a year earlier.

Analysts polled by Capital IQ expected $0.66.

Revenue for the quarter ended June 30, expressed as the sum of net interest income and noninterest income, was $163.8 million, up from $147.4 million a year earlier.

Analysts surveyed by Capital IQ expected $166.1 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug
Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug
Nov 15, 2024
NEW YORK, Nov 14 (Reuters) - Bristol Myers Squibb ( BMY ) was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a federal judge abruptly dismissed an earlier version of the case. The lawsuit accused Bristol Myers of depriving holders of contingent value rights...
Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
Nov 15, 2024
NEW YORK (Reuters) - Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a federal judge abruptly dismissed an earlier version of the case. The lawsuit accused Bristol Myers of depriving holders of contingent value rights (CVR) an extra $9 per...
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings
Nov 15, 2024
NEW YORK, Nov 14 (Reuters) - Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health ( CVS ) and added to existing bets and established a new position during the third quarter, according to regulatory filings. Longtime investor Glenview Capital Management bought 2.8 million CVS shares during the third quarter, increasing its stake...
US man sentenced to 5 years over laundering crypto stolen from Bitfinex hack
US man sentenced to 5 years over laundering crypto stolen from Bitfinex hack
Nov 15, 2024
WASHINGTON (Reuters) - A New York technology entrepreneur was sentenced to five years in prison on Thursday after pleading guilty last year to laundering funds stolen from Bitfinex one of the world's largest cryptocurrency exchanges, with the help of his wife. Ilya Lichtenstein, 35, hacked into Bitfinex's network in 2016, using advanced hacking tools and techniques, and stole about 120,000...
Copyright 2023-2026 - www.financetom.com All Rights Reserved